Reversal of antipsychotic-associated weight gain

Journal of Clinical Psychiatry

Volumn 64, Issue 8, 2003, Pages 907-912

  O'Keefe, Christopher D ^a,b   Noordsy, Douglas L ^a,b   Liss, Thomas B ^a   Weiss, Honey ^c  

^a Mental Hlth Ctr of Gtr Manchester   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; LITHIUM; NEUROLEPTIC AGENT; TOPIRAMATE; VALPROIC ACID;

ADULT; ARTICLE; BEHAVIOR THERAPY; DIET THERAPY; DIETITIAN; DRUG USE; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL RECORD; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; UNITED STATES; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0042011702     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0808     Document Type: Article

References (20)

1. Allison DB, Mentore JL, Heo M, et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. Am J Psychiatry 1999; 156: 1686-1696
2. Ganguli R. Weight gain associated with antipsychotic drugs. J Clin Psychiatry 1999;60(suppl 21):20-24
3. Wirshing DA, Wirshing WC, Kysar L, et al. Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry 1999;60:358-363
4. Taylor DM, McAkill R. Atypical antipsychotics and weight gain: a systematic review. Acta Psychiatr Scand 2000;101:416-432
5. Wetterling T, Mussigbrodt HE. Weight gain: side effect of atypical neuroleptics? J Clin Psychopharmacol 1999;19:316-321
6. Kinon BJ, Basson BR, Gilmore JA, et al. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 2001;62:92-99
7. Umbricht DSG, Pollack S, Kane JM. Clozapine and weight gain. J Clin Psychiatry 1994;55(suppl B):157-160
8. Crockford DN. Risperidone, weight gain and bulimia nervosa [letter]. Can J Psychiatry 1997;42:326-327
9. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994;151:825-835
10. Casey DE, Zorn SH. The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 2001;62(suppl 7):4-10
11. Kawachi I. Physical and psychological consequences of weight gain. J Clin Psychiatry 1999;60(suppl 21):5-9
12. Wirshing DA, Spellberg BJ, Erhart SM, et al. Novel antipsychotics and new onset diabetes. Biol Psychiatry 1998;44:778-783
13. Blackburn GL. Weight gain and antipsychotic medication. J Clin Psychiatry 2000;61(suppl 8):36-41
14. Green AI, Patel JK, Goisman RM, et al. Weight gain from novel antipsychotic drugs: need for action. Gen Hosp Psychiatry 2000;22:224-235
15. Anderson DA, Wadden TA. Treating the obese patient. Arch Fam Med 1999;8:156-167
16. Sachs GS, Guille C. Weight gain associated with use of antipsychotic medications. J Clin Psychiatry 1999;60(suppl 21):16-19
17. Siegel S, Castallen NJ. Nonparametric Statistics for the Behavioral Sciences. New York, NY: McGraw-Hill; 1988
18. Noordsy DL, O'Keefe C, Mueser KT, et al. Six-month outcomes for patients who switched to olanzapine treatment. Psychiatr Serv 2001;52: 501-507
19. American Psychiatric Association. Global Assessment of Functioning. In: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:32
20. New Hampshire Community Mental Health Services Administration. Adult Outcomes Measures Reference Manual. Concord, NH: New Hampshire Division of Behavioral Health; 1997